Instituto Nacional de Rehabilitación, Mexico City, Mexico.
Rheumatology Section, Center of Excellence of Rheumatology, Mexico City, Mexico.
Radiol Med. 2019 Oct;124(10):989-999. doi: 10.1007/s11547-019-01053-5. Epub 2019 Jul 2.
Lung ultrasound (LUS) achieved an intriguing role in the management of pulmonary involvement in patients affected by connective tissues diseases (CTDs). Few studies have been performed to support its usefulness in the evaluation of the presence and the severity of interstitial lung disease (ILD), relating it to the information obtained with chest high-resolution computed tomography (HRCT). These results open up new fields of research in order to demonstrate the utility of LUS as screening tool to evaluate ILD in CTD. The aim of this review is to provide the "state of the art" of the role of LUS in the management of ILD associated with CTD.
肺部超声（LUS）在管理结缔组织疾病（CTD）患者肺部受累方面发挥了引人注目的作用。虽然已经进行了一些研究来支持其在评估间质性肺疾病（ILD）的存在和严重程度方面的有用性，并将其与胸部高分辨率计算机断层扫描（HRCT）获得的信息相关联，但这些结果开辟了新的研究领域，以证明 LUS 作为评估 CTD 相关ILD 的筛查工具的效用。本综述的目的是提供 LUS 在管理与 CTD 相关的ILD 方面的“最新”作用。
